Versigent (VGNT) Director Brad M. Cerepak Receives Award

What Happened Brad M. Cerepak, a director of Versigent PLC (VGNT), received an award on 2026-09-18 consisting of 14.65 derivative units reported as acquired at $0.00 (transaction code A). The filing reports these as dividend equivalent rights tied to restricted stock units (RSUs); the reported acquisition value is $0.00 on the Form 4.

Key Details

• Transaction date: 2026-09-18; Form 4 filed 2026-09-22 (appears timely under the two-business-day rule).
• Transaction: Grant/award (A) of 14.65 units at $0.00 (derivative instrument).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote (F1): These are dividend equivalent rights that accrued on RSU grants due to a declared dividend; they vest on the same schedule as the related RSUs and are the economic equivalent of one ordinary share each.
• No sale, purchase for cash, or option exercise reported in this transaction.

Context This award represents compensation-related derivative units (dividend equivalents on RSUs) rather than an open-market purchase or sale. Such grants typically follow company compensation policies and vest according to the RSU schedule; they do not by themselves signal an insider buying or selling stock.